Literature DB >> 21120605

The effects of antidepressants on mitochondrial function in a model cell system and isolated mitochondria.

W Abdel-Razaq1, D A Kendall, T E Bates.   

Abstract

The in vitro effects of antidepressant drugs on mitochondrial function were investigated in a CHOβ(2)SPAP cell line used previously to determine the effects of antidepressants on gene transcription (Abdel-Razaq et al., Biochem Pharmacol 73:1995-2003, 2007) and in rat heart isolated mitochondria. Apoptotic effects of clomipramine (CLOM), desipramine (DMI) and of norfluoxetine (NORF, the active metabolite of fluoxetine), on cellular viability were indicated by morphological changes and concentration-dependent increases in caspase-3 activity in CHO cells after 18 h exposure to CLOM, DMI and NORF. However, tianeptine (TIAN) was without effect. CLOM and NORF both reduced integrated mitochondrial function as shown by marked reductions in membrane potential (MMP) in mitochondria isolated from rat hearts. DMI also showed a similar but smaller effect, whereas, TIAN did not elicit any significant change in MMP. Moreover, micromolar concentrations of CLOM, DMI and NORF caused significant inhibitions of the activities of mitochondrial complexes (I, II/III and IV). The inhibitory effects on complex IV activity were most marked. TIAN inhibited only complex I activity at concentrations in excess of 20 μM. The observed inhibitory effects of antidepressants on the mitochondrial complexes were accompanied by a significant decrease in the mitochondrial state-3 respiration at concentrations above 10 μM. The results demonstrate that the apoptotic cell death observed in antidepressant-treated cells could be due to disruption of mitochondrial function resulting from multiple inhibition of mitochondrial enzyme complexes. The possibility that antimitochondrial actions of antidepressants could provide a potentially protective pre-conditioning effect is discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21120605     DOI: 10.1007/s11064-010-0331-z

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  59 in total

Review 1.  A neurotrophic model for stress-related mood disorders.

Authors:  Ronald S Duman; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2006-04-21       Impact factor: 13.382

2.  Induction of apoptosis in proliferating lymphocytes by tricyclic antidepressants.

Authors:  H Karlsson; Y Gu; J DePierre; L Nässberger
Journal:  Apoptosis       Date:  1998-09       Impact factor: 4.677

3.  Differential effects of fluoxetine and imipramine on the phosphorylation of the transcription factor CREB and cell-viability.

Authors:  Jakob M Koch; Susanne Kell; Josef B Aldenhoff
Journal:  J Psychiatr Res       Date:  2003 Jan-Feb       Impact factor: 4.791

Review 4.  Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders.

Authors:  Vittorio Calabrese; Carolin Cornelius; Albena T Dinkova-Kostova; Edward J Calabrese; Mark P Mattson
Journal:  Antioxid Redox Signal       Date:  2010-08-28       Impact factor: 8.401

Review 5.  Mitochondria and degenerative disorders.

Authors:  M Orth; A H Schapira
Journal:  Am J Med Genet       Date:  2001

Review 6.  The role of mitochondria in the pathogenesis of neurodegenerative diseases.

Authors:  G Manfredi; M F Beal
Journal:  Brain Pathol       Date:  2000-07       Impact factor: 6.508

7.  beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria.

Authors:  L Canevari; J B Clark; T E Bates
Journal:  FEBS Lett       Date:  1999-08-20       Impact factor: 4.124

8.  Tianeptine, a new tricyclic antidepressant metabolized by beta-oxidation of its heptanoic side chain, inhibits the mitochondrial oxidation of medium and short chain fatty acids in mice.

Authors:  B Fromenty; E Freneaux; G Labbe; D Deschamps; D Larrey; P Letteron; D Pessayre
Journal:  Biochem Pharmacol       Date:  1989-11-01       Impact factor: 5.858

Review 9.  Mitochondrial diseases in man and mouse.

Authors:  D C Wallace
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

10.  Influence of receptor number on the stimulation by salmeterol of gene transcription in CHO-K1 cells transfected with the human beta2-adrenoceptor.

Authors:  J McDonnell; M L Latif; E S Rees; N J Bevan; S J Hill
Journal:  Br J Pharmacol       Date:  1998-10       Impact factor: 8.739

View more
  21 in total

Review 1.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

2.  Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy.

Authors:  Kiren Ubhi; Chandra Inglis; Michael Mante; Christina Patrick; Anthony Adame; Brian Spencer; Edward Rockenstein; Verena May; Juergen Winkler; Eliezer Masliah
Journal:  Exp Neurol       Date:  2012-01-16       Impact factor: 5.330

3.  In vitro effects of antidepressants and mood-stabilizing drugs on cell energy metabolism.

Authors:  Tereza Cikánková; Zdeněk Fišar; Jana Hroudová
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-12-19       Impact factor: 3.000

4.  Cannabinoid-Induced Changes in the Activity of Electron Transport Chain Complexes of Brain Mitochondria.

Authors:  Namrata Singh; Jana Hroudová; Zdeněk Fišar
Journal:  J Mol Neurosci       Date:  2015-03-29       Impact factor: 3.444

5.  Fluoxetine Treatment Rescues Energy Metabolism Pathway Alterations in a Posttraumatic Stress Disorder Mouse Model.

Authors:  Chi-Ya Kao; Zhisong He; Kathrin Henes; John M Asara; Christian Webhofer; Michaela D Filiou; Philipp Khaitovich; Carsten T Wotjak; Christoph W Turck
Journal:  Mol Neuropsychiatry       Date:  2016-04-30

6.  Modulation of Monoaminergic Systems by Antidepressants in the Frontal Cortex of Rats After Chronic Mild Stress Exposure.

Authors:  David Martín-Hernández; Marta P Pereira; Hiram Tendilla-Beltrán; José L M Madrigal; Borja García-Bueno; Juan C Leza; Javier R Caso
Journal:  Mol Neurobiol       Date:  2019-05-03       Impact factor: 5.590

7.  Antidepressant-like effects of ferulic acid: involvement of serotonergic and norepinergic systems.

Authors:  Jianliang Chen; Dan Lin; Chong Zhang; Gaowen Li; Nianping Zhang; Lina Ruan; Qizhi Yan; Jianxin Li; Xuefeng Yu; Xupei Xie; Cong Pang; Liang Cao; Jianchun Pan; Ying Xu
Journal:  Metab Brain Dis       Date:  2014-12-09       Impact factor: 3.584

Review 8.  Psychiatric drugs impact mitochondrial function in brain and other tissues.

Authors:  Shawna T Chan; Michael J McCarthy; Marquis P Vawter
Journal:  Schizophr Res       Date:  2019-11-16       Impact factor: 4.939

Review 9.  Drug-Induced Mitochondrial Toxicity.

Authors:  Iain P Hargreaves; Mesfer Al Shahrani; Luke Wainwright; Simon J R Heales
Journal:  Drug Saf       Date:  2016-07       Impact factor: 5.606

Review 10.  The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence.

Authors:  F Ferrari; R F Villa
Journal:  Mol Neurobiol       Date:  2016-08-10       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.